Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity

P. Puccetti, A. Santoni, C. Riccardi, H. T. Holden, R. B. Herberman

Research output: Contribution to journalArticle

Abstract

Inoculation of mice with pyran copolymer resulted in activation of natural killer (NK) cells as well as macrophages. Conditions optimal for the boosting of NK activity seemed to differ from those optimal for macrophage activation as assessed by cytostasis of tumor target cells. Peak levels of macrophage cytostatic reactivity were found at about 7 days after drug injection and were only achieved by the highest doses of pyran tested. Macrophage activation was consistently higher in the peritoneal cavity than in the spleen, regardless of route of administration, in contrast to the failure of i.v. pyran to induce high NK reactivity in peritoneal exudate cells. At 2-3 days after pyran treatment in older mice, NK augmentation reached peak levels, but only minimal macrophage activation was found. Despite these differences, macrophages played a role in regulating NK activity in pyran-treated mice. Functional macrophages appeared to be required for augmentation of NK activity by pyran, since boosting was impaired by prior in vivo inoculation of silica. Macrophages also appeared able to inhibit NK activity. In younger mice that exhibited high spontaneous levels of NK activity, pyran treatment produced a substantial reduction in NK activity to levels below those of untreated mice. This depression coincided with the time of peak levels of macrophage cytostasis. Furthermore, removal of adherent cells from the spleen cells of these pyran-treated mice resulted in levels of NK activity almost as high as those of untreated mice. The possibility that the depression of NK activity in young mice by pyran copolymer is due to suppressor cells is discussed.

Original languageEnglish
Pages (from-to)819-825
Number of pages7
JournalInternational Journal of Cancer
Volume24
Issue number6
DOIs
Publication statusPublished - 1979

Fingerprint

Pyran Copolymer
Macrophage Activation
Pyrans
Macrophages
Spleen
Peritoneal Cavity
Cytostatic Agents
Exudates and Transudates
Silicon Dioxide
Natural Killer Cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity. / Puccetti, P.; Santoni, A.; Riccardi, C.; Holden, H. T.; Herberman, R. B.

In: International Journal of Cancer, Vol. 24, No. 6, 1979, p. 819-825.

Research output: Contribution to journalArticle

Puccetti, P. ; Santoni, A. ; Riccardi, C. ; Holden, H. T. ; Herberman, R. B. / Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity. In: International Journal of Cancer. 1979 ; Vol. 24, No. 6. pp. 819-825.
@article{c9b4fbd871c741e3b88ae3de7a25cee4,
title = "Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity",
abstract = "Inoculation of mice with pyran copolymer resulted in activation of natural killer (NK) cells as well as macrophages. Conditions optimal for the boosting of NK activity seemed to differ from those optimal for macrophage activation as assessed by cytostasis of tumor target cells. Peak levels of macrophage cytostatic reactivity were found at about 7 days after drug injection and were only achieved by the highest doses of pyran tested. Macrophage activation was consistently higher in the peritoneal cavity than in the spleen, regardless of route of administration, in contrast to the failure of i.v. pyran to induce high NK reactivity in peritoneal exudate cells. At 2-3 days after pyran treatment in older mice, NK augmentation reached peak levels, but only minimal macrophage activation was found. Despite these differences, macrophages played a role in regulating NK activity in pyran-treated mice. Functional macrophages appeared to be required for augmentation of NK activity by pyran, since boosting was impaired by prior in vivo inoculation of silica. Macrophages also appeared able to inhibit NK activity. In younger mice that exhibited high spontaneous levels of NK activity, pyran treatment produced a substantial reduction in NK activity to levels below those of untreated mice. This depression coincided with the time of peak levels of macrophage cytostasis. Furthermore, removal of adherent cells from the spleen cells of these pyran-treated mice resulted in levels of NK activity almost as high as those of untreated mice. The possibility that the depression of NK activity in young mice by pyran copolymer is due to suppressor cells is discussed.",
author = "P. Puccetti and A. Santoni and C. Riccardi and Holden, {H. T.} and Herberman, {R. B.}",
year = "1979",
doi = "10.1002/ijc.2910240621",
language = "English",
volume = "24",
pages = "819--825",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity

AU - Puccetti, P.

AU - Santoni, A.

AU - Riccardi, C.

AU - Holden, H. T.

AU - Herberman, R. B.

PY - 1979

Y1 - 1979

N2 - Inoculation of mice with pyran copolymer resulted in activation of natural killer (NK) cells as well as macrophages. Conditions optimal for the boosting of NK activity seemed to differ from those optimal for macrophage activation as assessed by cytostasis of tumor target cells. Peak levels of macrophage cytostatic reactivity were found at about 7 days after drug injection and were only achieved by the highest doses of pyran tested. Macrophage activation was consistently higher in the peritoneal cavity than in the spleen, regardless of route of administration, in contrast to the failure of i.v. pyran to induce high NK reactivity in peritoneal exudate cells. At 2-3 days after pyran treatment in older mice, NK augmentation reached peak levels, but only minimal macrophage activation was found. Despite these differences, macrophages played a role in regulating NK activity in pyran-treated mice. Functional macrophages appeared to be required for augmentation of NK activity by pyran, since boosting was impaired by prior in vivo inoculation of silica. Macrophages also appeared able to inhibit NK activity. In younger mice that exhibited high spontaneous levels of NK activity, pyran treatment produced a substantial reduction in NK activity to levels below those of untreated mice. This depression coincided with the time of peak levels of macrophage cytostasis. Furthermore, removal of adherent cells from the spleen cells of these pyran-treated mice resulted in levels of NK activity almost as high as those of untreated mice. The possibility that the depression of NK activity in young mice by pyran copolymer is due to suppressor cells is discussed.

AB - Inoculation of mice with pyran copolymer resulted in activation of natural killer (NK) cells as well as macrophages. Conditions optimal for the boosting of NK activity seemed to differ from those optimal for macrophage activation as assessed by cytostasis of tumor target cells. Peak levels of macrophage cytostatic reactivity were found at about 7 days after drug injection and were only achieved by the highest doses of pyran tested. Macrophage activation was consistently higher in the peritoneal cavity than in the spleen, regardless of route of administration, in contrast to the failure of i.v. pyran to induce high NK reactivity in peritoneal exudate cells. At 2-3 days after pyran treatment in older mice, NK augmentation reached peak levels, but only minimal macrophage activation was found. Despite these differences, macrophages played a role in regulating NK activity in pyran-treated mice. Functional macrophages appeared to be required for augmentation of NK activity by pyran, since boosting was impaired by prior in vivo inoculation of silica. Macrophages also appeared able to inhibit NK activity. In younger mice that exhibited high spontaneous levels of NK activity, pyran treatment produced a substantial reduction in NK activity to levels below those of untreated mice. This depression coincided with the time of peak levels of macrophage cytostasis. Furthermore, removal of adherent cells from the spleen cells of these pyran-treated mice resulted in levels of NK activity almost as high as those of untreated mice. The possibility that the depression of NK activity in young mice by pyran copolymer is due to suppressor cells is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0018604707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018604707&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910240621

DO - 10.1002/ijc.2910240621

M3 - Article

C2 - 232496

AN - SCOPUS:0018604707

VL - 24

SP - 819

EP - 825

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -